Biotech δημόσια
[search 0]
Περισσότερα

Download the App!

show episodes
 
Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.
 
San Diego has grown into one of the largest biotechnology hubs in the United States with some very talented people doing very exciting things. Come along with me as I explore the world of biotech, meet some interesting people, and maybe even learn a thing or two. Oh wait… did I mention there will be beer?
 
I
Inside Biotech

1
Inside Biotech

Dr. Yewande Pearse, Kathy Grotsch, Ananta Wadhwa

Unsubscribe
Unsubscribe
Μηνιαία
 
Inside Biotech is an exciting new podcast from BCLA, which focuses on the science behind SoCals most innovative new biotech companies. This monthly podcast, hosted by Dr. Yewande Pearse, Media & Marketing Associate at BCLA, is the perfect way for LA’s biotech community to stay informed about current progress and developments, and features conversations with scientists, entrepreneurs, and investors about the cutting edge science that goes on inside their companies. On Inside Biotech, science ...
 
Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.
 
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by BioProcess Online and brought to you by Cytiva, former ...
 
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday.The host is Jim Cornall.
 
B
BioTech IQ

1
BioTech IQ

Ammon Rivera

Unsubscribe
Unsubscribe
Μηνιαία+
 
Increase your IQ and understanding of the Biotech industry by listening to interviews with key business leaders who have built successful companies and departments. We discuss everything from the science, clinical operations, clinical development, safety/PV and more! We address how each function plays an important role in the drug approval process. We also discuss the people that make up these departments. Get ready to hear about cutting edge development and the people who make it happen!
 
Welcome to the Combinate Podcast, a show that is bridging the gap between MedTech and BioTech. My name is Subhi Saadeh, I'm an engineer and for the last decade I've sought to broaden my understanding in these industries, and have been amazed at the wonderful people I've met and the insights they've given me. Each week I sit down with leaders to discuss their expertise, the lessons they learned and continue that mission.
 
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management
 
Horizon 3 is a biotech fund which has been formed to help investors to have a real impact on a range of global health challenges through new bio technologies, aiming to de-risk the investment risks inherent in such a technical area.These podcasts are a series aimed at educating investors on the issues, risks and opportunities involved in investing ion the biotech sector.
 
Welcome to the RE-LAUNCH of BIOTECH NATION !!! Since 2004, the public radio program "Tech Nation" has followed biotech's journey from the science lab to actual products in its regular segment, "BioTech Nation". With understandable interviews - requiring no background science - BTN attracts a wide audience. From everyday people looking for hope in potential future treatments, to entrepreneurs interested in the experience of their fellow travelers, to venture capitalists seeing possibilities i ...
 
Encode Ideas authors research on publicly traded micro / small cap healthcare (biotech & medtech) companies. The Plainspoken podcast is an extension of our research, where we will interview executives from micro / small cap health care companies, portfolio managers who invest in micro / small cap healthcare, and key opinion leaders who can offer insights into therapeutics areas of interest to investors. The podcast is for entertainment purposes only and should not be considered financial adv ...
 
Interviews with the researchers, founders, and investors of the BioTech industry. An insiders look into what is going on in the world of BioTech, from curing aging to psychedelic therapy, we interview the game changers of the industry. The unsung hero's that are moving the industry forward in a significant way. The world is going to be a vastly different place in the next 10-20 years because of what's happening in the BioTech industry right now.Human civilization will move forward farther, f ...
 
Loading …
show series
 
Anthocyanins are a class of plant pigments associated with healthful qualities in food. While research continues to assess their true health benefits in vivo, there is no question that the attractive fruits stimulate the senses and bring novelty to the diet. Dr. Cathie Martin of the John Innes Center in Norwich, England discusses the technology beh…
 
02:17 Labiotech.eu news 04:59 TikoMed 09:20 Pleco Therapeutics 25:45 Cullinan Oncology/World Cancer Research Day 44:15 JLL This week’s podcast has three guests. In honor of World Cancer Research Day on September 24, we have an overview of cancer research with Nadim Ahmed, CEO of Cullinan Oncology; a chat with Ivo Timmermans, CEO of Pleco Therapeuti…
 
In this episode of the Biotech and Breweries Podcast, Andy Kelly, Head Brewer at Embolden Beer shares three exciting beers from the San Diego based brewery. Lights & Music lager, Broken Record IPA, and Electric Feel, an 18-month Bourbon barrel aged imperial coffee stout. Andy shares how Embolden Brewing is defying the expectations of traditional br…
 
Interested in purchasing the book? Order here: https://amzn.to/3R4RWfTAnkit Mahadevia is the founder and CEO of Spero Therapeutics, an organization committed to fighting the threat of infectious disease through the development of novel medicines. Over his career, he has led the formation of nine companies, including Spero, several of which are trad…
 
On this episode, I was joined by Bassil Akra, the CEO of AKRA Team. Bassil and I discuss: EU MDR and Implementation Timeframe Notified Bodies, Competent Authorities, MOH's and the EU Commission Article 117 & Drug/Device Combination Products Differences between MDD and MDR for Economic Operators His Favorite Book: EU MDR Dr. Bassil Akra spent the la…
 
A bit more about our guests: As an accomplished management expert with 25 years experience, Damien is a recognized life science executive coach and excels at transforming unassuming scientists into inspiring and influential leaders. He specializes in guiding scientists to not only create high impact lab environments, but also foster captivating and…
 
At biotech companies, things often evolve at light speed, and the natural tendency of a Chief Medical Officer (CMO) can be to try and manage every detail. But it’s a superhuman task, especially when powerful egos are in play. This episode of The Emerging Biotech Leader features: Dr. Ramin Farhood, Vice President of Medical Affairs, SSI Strategy Kim…
 
Using computational biology to hasten the effort, Omega Therapeutics' plan is to "coopt nature's universal biological operating system for gene control and cell differentiation." On this episode of the Business of Biotech, we dig into exactly what that means. We also explore the company's preclinical ambitions, which are diverse, targeting regenera…
 
Discussing the formation of CRISPR Tx, the positives, negatives and everything in between. This is the first time all three of us reconnected since our respective departures from our founding roles and features some candid moments from our respective journeys. Enjoy.Από τον Nessan Bermingham PhD
 
This week on the podcast Agustin discusses news around Amgen's big 1L data drop for its KRAS inhibitor Lumakras, the shifting perceptions for $AMLX and what could become an approval for their ALS therapy, and the shortsightedness of the FDA and CDC around approving covid boosters based only on mouse data! If you are a fan of this show make sure to …
 
AI has gone so far as to potentially change drug development, and these developments have the potential to make a difference in people’s lives. On this episode of BioTech IQ, Ammon interviews Noam Solomon, the CEO of Immunai. Immunai is developing an AI platform that leverages big data, single cell multiomics, and machine learning to bridge the gap…
 
Dr. Shelley Ackerman is an Associate Director & Program Team Lead at Bolt Biotherapeutics. Bolt is a clinical-stage biotechnology company pioneering a new class of immuno-oncology agents that combine the targeting precision of antibodies with the power of both the innate and adaptive immune systems. Bolt Biotherapeutics’ proprietary Boltbody™ Immun…
 
Anat Shani, the CEO of Synchrony Medical and Dr. Moshe Ashkenazi, one of the co-founders spoke with Avraham about their wearable bio-tech product, the LibAirty, which is a home-use airway clearance system to help patients with chronic lung diseases maintain clear lungs with short, daily treatments.Avraham sat down with Anat and Moshe in the offices…
 
Sexually transmitted infections like chlamydial and gonorrhea are making a comeback, especially with younger demographics. Part of the problem is the stigma of examination and testing. These are not trivial infections, and can result in more complicated syndromes, which could include sterility or issues reproductive health. Early, discrete, confide…
 
2:56 News 5:42 NLS Days - overview 17:42 NLS Days - NLSInvest 29:35 NLS Days - AstraZeneca 42:13 JLL Beyond Biotech Podcast 14: Nordic Life Science Days 2022 This week’s podcast is dedicated to Nordic Life Science Days, otherwise known as NLS Days. This year’s version is an in-person event from September 28-29, at the Malmömässan in Malmö, Sweden. …
 
Christopher PosnerChief Executive Officer, President, and DirectorMr. Posner has served as our President and Chief Executive Officer since November 2021 and has served as a member of our Board since August 2018. He has broad experience in commercial and marketing operations and product management at both large and specialty pharmaceutical companies…
 
On this episode, I was joined by Dr. James Somauroo of SomX and The HealthTech Podcast. James and I discuss: HealthTech Communication Growing a Passion The HealthTech Podcast Healthtech Pigeon Delegating vs. Creating Systems James is the founder of SomX: The Healthtech Agency and supports the best healthtech companies in the world. He covers health…
 
Loading …

Οδηγός γρήγορης αναφοράς

Google login Twitter login Classic login